Warfarin Sodium News
FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium ... - Earthtimes
Patients on warfarin (such as Coumadin(R)) may need to be monitored more closely by their doctor. To learn more, talk to your doctor and see the full ...
China blacklists 141 seriously polluting products - Xinhua
The list included products closely linked to people's daily life, such as warfarin, mirex, DDT and nickel-cadmium cell, said Pan Yue, State Environmental ...
China blacklists 141 seriously polluting products - People's Daily Online
The list included products closely linked to people's daily life, such as warfarin, mirex, DDT and nickel-cadmium cell, said Pan Yue, State Environmental ...
Encysive Pharmaceuticals Launches Thelin (Sitaxentan Sodium) in Sweden - PharmaLive.com (press release)
Because THELIN inhibits the metabolism of warfarin and other vitamin K antagonists, a dose adjustment for these drugs is needed when co-administered with ...
China blacklists 141 seriously polluting products - China Daily
The list included products closely linked to people's daily life, such as warfarin, mirex, DDT and nickel-cadmium cell, said Pan Yue, deputy director of the ...
FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium ... - Earthtimes
Patients on warfarin (such as Coumadin(R)) may need to be monitored more closely by their doctor. To learn more, talk to your doctor and see the full ...
DC Hospital Pioneers WATCHMAN Device - Nurse.com
All of them have come off the anticoagulant Coumadin (warfarin sodium) and have experienced no adverse events. About 645 people have received the device ...
Encysive Pharmaceuticals Launches THELIN (Sitaxentan Sodium) in Sweden - CNNMoney.com
Because THELIN inhibits the metabolism of warfarin and other vitamin K antagonists, a dose adjustment for these drugs is needed when co-administered with ...
Boehringer Ingelheim Announces Enrollment Is Complete For The ... - Medical News Today (press release)
The RE-LY trial is comparing two blinded doses of oral dabigatran etexilate with warfarin sodium (target INR 2.0-3.0) in patients with non-valvular atrial ...
Boehringer Ingelheim Announces Enrollment is Complete for the ... - Earthtimes
The RE-LY trial is comparing two blinded doses of oral dabigatran etexilate with warfarin sodium (target INR 2.0-3.0) in patients with non-valvular atrial ...
Warfarin Sodium RSS Feed